EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Application of genetic testing for the diagnosis of von Willebrand disease

Omid Seidizadeh, Luciano Baronciani, David Lillicrap, Flora Peyvandi

Journal of Thrombosis and Haemostasis · 2024

DOI: 10.1016/j.jtha.2024.05.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Omid Seidizadeh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathoph…. Hauptthemen laut MEDLINE: von Willebrand Factor, Genetic Testing, von Willebrand Diseases, Phenotype. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

von Willebrand disease (VWD) is the most frequent inherited bleeding disorder, with an estimated symptomatic prevalence of 1 per 1000 in the general population. VWD is characterized by defects in the quantity, quality, or multimeric structure of von Willebrand factor (VWF), a glycoprotein being hemostatically essential in circulation. VWD is classified into 3 principal types: low VWF/type 1 with partial quantitative deficiency of VWF, type 3 with virtual absence of VWF, and type 2 with functional abnormalities of VWF, being classified as 2A, 2B, 2M, and 2N. A new VWD type has been officially recognized by the ISTH SSC on von Willebrand factor which has also been discussed by the joint ASH/ISTH/NHF/WFH 2021 guidelines (ie, type 1C), indicating patients with quantitative deficiency due to an enhanced VWF clearance. With the advent of next-generation sequencing technologies, the process of genetic diagnosis has substantially changed and improved accuracy. Therefore, nowadays, patients with type 3 and severe type 1 VWD can benefit from genetic testing as much as type 2 VWD. Specifically, genetic testing can be used to confirm or differentiate a VWD diagnosis, as well as to provide genetic counseling. The focus of this manuscript is to discuss the current knowledge on VWD molecular pathophysiology and the application of genetic testing for VWD diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Willebrand FactorGenetic Testingvon Willebrand DiseasesPhenotypeHumansPredictive Value of TestsGenetic Predisposition to DiseaseMutationGenetic Counseling

Stichwörter der Autor:innen

NGSVWDVWFgenetic testingmolecular diagnosis

Substanzen

von Willebrand Factor

Autor:innen und Institutionen

  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan,…
  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: https://twitter.com/DavidLillicrap.

Förderung

  • NHLBI NIH HHS
  • Ministero della Salute

Zitieren

APA

Seidizadeh, O., Baronciani, L., Lillicrap, D., & Peyvandi, F. (2024). Application of genetic testing for the diagnosis of von Willebrand disease. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.05.006

Vancouver

Seidizadeh O, Baronciani L, Lillicrap D, Peyvandi F. Application of genetic testing for the diagnosis of von Willebrand disease. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.05.006

BibTeX
@article{Seidizadeh2024,
  author = {Seidizadeh, Omid and Baronciani, Luciano and Lillicrap, David and Peyvandi, Flora},
  title = {Application of genetic testing for the diagnosis of von Willebrand disease},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  doi = {10.1016/j.jtha.2024.05.006}
}
Kostenlos starten →